Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The most significant published evidence to date comes from a phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023, which evaluated retatrutide across multiple doses in adults with obesity
Within a research context, this molecule is known for its function as a triple receptor agonist (GLP-1, GIP, and glucagon)
Are there specific clinical criteria required for approval (e.g., BMI thresholds, sustained weight requirements, step therapy such as participation in a weight management program)
Does Medicare cover tirzepatide
No inference should be drawn regarding human wound healing, tissue repair, therapeutic efficacy, safety, or suitability for any human, cosmetic, wellness, fitness, or veterinary application
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
